Showing results (111-120 of 217) with videos related to
Sort By:
Pageof 22
Peerj|August 9, 2019
Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancerZoltan Lohinai, Laura Bonanno, Aleksei Aksarin, et al.Stem Cells (Dayton, Ohio)|November 28, 2014
Mesenchymal progenitors aging highlights a miR-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesisOlivia Candini, Carlotta Spano, Alba Murgia, et al.Thoracic Cancer|November 21, 2020
Estimated direct costs of non-small cell lung cancer by stage at diagnosis and disease management phase: A whole-disease modelAlessandra Buja, Michele Rivera, Anna De Polo, et al.Biochimica Et Biophysica Acta|February 11, 2014
Targeting bone metastatic cancer: Role of the mTOR pathwayFrancesco Bertoldo, Franco Silvestris, Toni Ibrahim, et al.The New England Journal of Medicine|June 6, 2017
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA MutationMark Robson, Seock-Ah Im, Elżbieta Senkus, et al.Cancer Treatment Reviews|June 1, 2014
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trialsEmilio Bria, Luisa Carbognin, Jenny Furlanetto, et al.NPJ Breast Cancer|October 13, 2021
Evolution of HER2-low expression from primary to recurrent breast cancerFederica Miglietta, Gaia Griguolo, Michele Bottosso, et al.NPJ Breast Cancer|February 13, 2021
Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancerGaia Griguolo, Maria Vittoria Dieci, Laia Paré, et al.Oncotarget|April 22, 2017
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutationsStefano Frega, Martina Lorenzi, Matteo Fassan, et al.Pathology Oncology Research : POR|September 26, 2006
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondriaKatalin Nagy, Kinga Székely-Szüts, Kamel Izeradjene, et al.Pageof 22